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ABSTRACT 
Objective: Mouse models of SUDEP using Audiogenic Seizures (AGS) are valuable because death 
can occur following a sound-induced seizure in the absence of any pharmacologic or electric 
component. However, only a few strains of mice are AGS prone and the vast majority of studies 
involve DBA/2 or DBA/1 inbred strains. With the goal to characterize the variation of AGS 
susceptibility with age, and to offer a larger panel of mice available for AGS studies, we performed a 
comparative study of the variability in AGS responses. 
Methods: The variation of AGS with age was determined in two classically used inbred strains of 
mice, DBA/2 and DBA/1, and two additional strains, BALB/c and 129/SvTer. As AGS stimulated 
tonic seizures can be lethal or non-lethal, even in the same inbred strain, in a second experiment, we 
addressed whether there is an innate capacity to reproduce the same response after a tonic seizure in 
AGS, referred to as “determinism”, in the DBA/2J, DBA/1J, and 129/SvTer mouse strains.  
Results: Results show that the 129/SvTer mouse is a more versatile model of SUDEP due its wider 
age range of susceptibility compared to the DBA/2J and DBA/1J mouse strains. In addition, we show 
that determinism is not consistently evident in DBA/2J and 129/SvTer strains after AGS. Hence, one 
cannot be certain that a lethal AGS will always be lethal in a successive testing after resuscitation and 
vice versa in these two mouse strains.  
Significance: These studies highlight the phenotypic variability of AGS in different mouse strains, 
show the value of an additional mouse strain, the 129/SvTer for studies using AGS, and, thus, provide 
valuable information for future studies of AGS and SUDEP. 
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INTRODUCTION 
Animal models of sudden unexpected death in epileptic patients (SUDEP) have been valuable tools 
used to explore the underlying mechanisms of this phenomenon in hopes of treating and preventing 
death due to epilepsies1-6. Typically mouse models of SUDEP use audiogenic seizures (AGS), induced 
with a sound stimulation, to induce SUDEP7. Immediately after the sound presentation, the mouse 
manifests a stereotyped behavior for which one can identify successively wild running, a clonic 
seizure, a tonic-clonic seizure when the mouse falls on its flanks, and a tonic seizure with an extension 
of the limbs toward the tail, followed, or not, by death. AGS in mice represents a valuable model for 
SUDEP as death can result after seizure7, 8 when using non-invasive techniques without any 
pharmacologic or electrical component and because there is a shared respiratory mechanism of death 
in both SUDEP and AGS models 5, 9-12. 
 
Only a few strains of mice are AGS prone with the vast majority of studies involving DBA/2 or, 
recently, DBA/1 inbred strains. For example, DBA/2 mice show AGS which appears to be age 
dependent with younger mice being more prone to AGS13. AGS in DBA/1 mice is evident from 
postnatal days 21 to 10014. The vast majority of the AGS studies involve the DBA/2 inbred strain 
simply because 1) it is an AGS responder, and 2) it is a mouse strain that is well described genetically 
and phenotypically. Recently the DBA/1 has been highlighted as an alternate model of AGS for its 
larger time frame of susceptibility, despite the lack of data about this strain compared to the DBA/2 
strain. However, there are a number of emerging problems with the DBA substrains such as the 
decreasing AGS susceptibility with age and their fragility (ie. stunted growth) which make it difficult 
to do further investigations of SUDEP that would require surgical manipulations.  
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Thus, with the goal to offer alternative mouse strains for AGS studies, we characterized AGS 
susceptibility in two strains of mice, BALB/c and 129/SvTer, that we have chosen based on the work 
of Fuller and Sjursen (1967)15. We characterized the variability in AGS responses during 13 weeks in 
the two strains of mice, BALB/c and 129/SvTer, not previously studied in AGS beyond the work of 
Fuller and Sjursen (1967), as well as in two currently used inbred strains of mice for AGS, DBA/2 and 
DBA/1. The experiments were conducted on independent groups of mice at different ages, from days 
21 to 112 of age, and for each testing time, we recorded the percentages of mice 1/ presenting no 
seizure or just wild running, 2/ presenting clonic seizures without a tonic seizure, 3/ presenting a non-
lethal tonic seizure, 4/ presenting a lethal tonic seizure after AGS. None of the groups received 
priming. Priming is commonly used in models of AGS and represents a type of kindling where, at a 
critical age, a mouse is subjected to AGS during several consecutive days and then reintroduced to 
AGS at a later age 6. This is expected to maximize the severity of the AGS response. In fact, priming 
can create susceptibility to AGS even in mouse strains that do not acutely respond to AGS 2-4, 16. 
 
In order to study pharmacological interventions for SUDEP in mouse models, one often gives the 
pharmacological intervention after the mouse has been resuscitated after cardio-respiratory arrest 
induced by AGS and then tests the mouse for AGS response with the assumption that without the 
pharmacological intervention the mouse would have cardio-respiratory arrest after AGS (ie. 
determinism). This concept of determinism, that the same innate response will occur in response to 
the same stimulus under the same conditions, is often applied to lethal (experimentally a seizure-
induced respiratory arrest or SIRA) and non-lethal AGS (non-SIRA) with the assumption that a SIRA 
is followed by a SIRA during the next test or a non-SIRA is followed by a non-SIRA during the next 
test. Thus, to further investigate this idea of determinism, that once a mouse experiences a SIRA, it 
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will always experience a SIRA and vice versa, in a second study we tested and re-tested the same 
animal for SIRA or non-SIRA responses, with a resuscitating gesture after the first test if necessary. 
 
METHODS 
Animals. Male and female mice from DBA/2J, DBA/1J, BALB/cJ, and 129/SvTer strains were used 
in the present study. We chose the DBA/2J and DBA/1J strains because they are established models 
of AGS. We also chose BALB/cJ and 129/SvTer mice as comparison groups as work suggests that 
they present a contrasted susceptibility to AGS15. The 4 mouse strains are maintained at the University 
of Rennes 1 animal facility. Mice used for the present study were housed in cages of 3 to 5 individuals 
of the same sex and age with ad libitum access to tap water and standard mouse chow. Lights were 
maintained in a 12:12 hour cycle with lights on at 7:30a.m. All care and experimental manipulation of 
the animals were carried out in accordance with the guidelines of the European Union (directive 
2010/63/EU). Weight growth curves for DBA/1J and 129/SvTer mice were generated up to the age of 
100 days. 
 
Experiment 1: AGS in four strains of mice 
Each week from 21-112 days of age, an independent sample of animals averaging between 17-25 
animals for each of the 4 strains was subjected to the same sound stimulus. The presentation of the 
sound occurred in a sound proof chamber to ensure that non-experimental animals would not be 
disturbed. During testing, each mouse was individually subjected to a 110 dB and 12 kHz sound 
stimulus created by a sonicator (Deltasonic model Delta 920) in a circular plastic enclosure, 30 cm in 
diameter and 35 cm in height. The sound stimulus was stopped as soon as the tonic seizure appeared 
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or after 60 sec without response. We counted: a) the number of mice without seizures, b) the number 
of mice with clonic seizures only, c) the number of mice with a non-lethal tonic seizure, d) the number 
of mice with lethal tonic seizures. The results of this portion of the study are described below and 
presented in Figure 1.  
 
Experiment 2: An investigation of determinism 
To address the question of determinism, a further experiment took place with DBA/2Jand 129/SvTer 
strains. These mouse strains were subjected to AGS for days. DBA/2J mice were subjected to AGS 
for 2 consecutive days and 129/SvTer mice were subjected to AGS for 5 consecutive days. For this 
repeated AGS testing, DBA/2J mice (28-35 days of age) and 129/SvTer mice (35-70 days of age) were 
exposed to a sound as described above. Only mice that showed an AGS that was tonic in nature on 
each day of testing were included in this analysis. It should be noted that hearing loss is a common 
feature with the strains of mice used in AGS studies17-19. However, hearing loss was not a concern in 
this experiment as only animals that responded to AGS with a tonic seizure were included in this study. 
Therefore, they had to hear the sound stimulation. 
If an animal had cardio-respiratory arrest after seizure it was resuscitated 2-3 seconds after ear 
relaxation with a respirator (1.25ml, 180 bpm; Columbus Instruments CIV-101). This resulted in a 
series of SIRA and non-SIRA for each mouse; 2 values for DBA/2J and 5 values for 129/SvTer mice. 
Considering the large percentage of DBA/2J mice not presenting with a tonic seizure as an initial AGS 
response at this age, which was a criterion for this experiment, a large number of animals would be 
needed for 5 days of testing. Thus, it was only feasible to test this strain for 2 consecutive days. Testing 
the 129/SvTer strain for 5 consecutive days was feasible as the percentage of animals that present with 
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a tonic seizure after a first AGS is high (approx. 90%). It should also be noted that this protocol cannot 
be assimilated to a priming procedure since only susceptible mice, characterized by at least a tonic 
seizure at both test and restest, were included. 
DBA/1J mice (35-42 days of age) were also used in this test-retest experiment but these mice 
rarely present with non-lethal tonic seizure in response to AGS (Figure 1). Effectively, to test 
determinism it is necessary to have mice that can present with a tonic seizure followed by death or a 
tonic seizure without death. Thus, interpretations with regards to determinism for DBA/1J mice are 
limited. . DBA/1J mice were tested on 2 consecutive days for AGS as described above. BALB/c mice 
were not used as they do not present with tonic seizures in response to AGS.  
Statistical analyses. The determinism in the DBA/2J and 129/SvTer strains was tested by comparing 
the response to AGS across the first two days of testing. A Cohen’s Kappa coefficient was used to test 
whether mice had the same response (SIRA/non-SIRA) at both times. This coefficient takes into 
account the possibility of a similar response between both times occurring by chance. Kappa 
coefficients over 0.75 are usually considered as excellent, 0.40 to 0.75 as fair to good and below 0.40 
as poor. Conditional probabilities of death at day 2 (according to SIRA/non-SIRA at day 1) were 
produced and compared between strains using a Fisher’s exact test.  For the 129/SvTer strain, the same 
conditional probabilities were produced for the 5 consecutive days of experiment: we computed the 
probabilities to have a cardio-respiratory arrest after experiencing an AGS on the preceding day. A 
cumulative effect of repeated SIRA experiences was tested by summing the number of times through 
days 1 to 4 the mice had SIRA. This number was compared to the response at day 5 (SIRA/non-SIRA) 
using a Fisher’s exact test and we computed the probability of SIRA at day 5 conditionally to the 
number of SIRA experiences on the preceding days. In the same way, the number of times the mouse 
had experienced SIRA through day 2 to day 5 was cross-tabulated according to its first response 
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(SIRA/non-SIRA) at day 1 in order to assess the capacity of the response at day 1 to predict the 
responses on the following days. A Fisher’s exact test was computed to assess statistical significance 
of the prediction.  
To illustrate the better fitness of 129/SvTer strain to invasive experiments, we modeled the weight 
growth curve of 129/SvTer and DBA/2J mice from 23 and up to 88 days of age using non-linear mixed 
effects models, for males and females separately (random intercept, fixed effects of age and strain). 
The interaction of strain and age allowed for testing differential weights along the growth curve 
between strains. 
Statistical significance was set at 5%. Analyses were computed using the SAS® software. 
 
RESULTS 
Experiment 1. The four strains of mice presented with different responses to the AGS and differences 
in AGS response with age. In response to sound stimulation, the DBA/2J strain presented with 4 groups 
of mice characterized by their AGS response (no response, clonic seizures, non-lethal tonic seizures 
and lethal tonic seizures). The presence of tonic seizures after sound stimulation was very high at 21 
days of age and, with age, there was a rapid extinction of AGS response in the DBA/2J strain. The 
DBA/1J strain at 21 days of age had a much lower susceptibility to AGS, but had a relatively stable 
phenotype over time with sound stimulation resulting in a majority of lethal tonic seizures or no seizure 
at all. In response to sound stimulation, the 129/SvTer strain presented with 3 groups of mice 
characterized by their AGS response (no response, non-lethal tonic seizures, lethal tonic seizures). 
With age, there was an increase of tonic seizure response during AGS in 129/SvTer mice. Finally, the 
BALB/cJ strain showed an absence of tonic seizures (see Figure 1). 
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When investigating the growth curves of DBA/1J and 129/SvTer (Figure 2), we found that 129/SvTer 
mice were significantly heavier than DBA/1J mice: in males (βstrain=11.7, p=0.03 and interaction 
βstrain*age=5.1, p=0.0001) and females (βstrain=11.3, p=0.07 and interaction βstrain*age=4.9, p=0.001).  
 
Experiment 2. An investigation of the determinism in the DBA/2J, DBA/1J and 129/SvTer strains 
across two days of testing showed that the determinism hypothesis was rejected based on the data 
collected from both DBA/2J mice (kappa=0.23, Figure 3) and 129/SvTer mice (kappa=0.28, Figure 
3). This result is clearly illustrated when we investigate 5 consecutive days of AGS in 129/SvTer mice 
where only 54.5% of mice consistently showed 5 consecutive days of SIRA or non-SIRA. However, 
even if one rejects the idea of determinism, we observed that in 129/SvTer mice the probability to 
have a SIRA was higher when a SIRA was experienced the day before. After daily AGS testing, the 
probability of a SIRA on the 5th day of testing was correlated to the number of SIRA on the previous 
days (Fisher's exact test p<0.0001, Figure 4). In addition, when looking at predictability of a SIRA or 
non-SIRA after the first AGS, if a mouse experienced a SIRA on the 1st day of testing there was a 40% 
chance that the mouse would not have another SIRA. On the other hand, if an AGS was not lethal on 
the 1st day of testing, there was a 65% chance that the mouse would not experience SIRA with 
additional AGS (Fisher’s exact test, p<0.0001). Interestingly, there were strain differences in the 
response to the first AGS experience such that in DBA/2J mice 80% of the mice that had a SIRA on 
day 1 also had a SIRA on day 2, and only 43% of mice that had a non-SIRA on day 1 had a non-SIRA 
on day 2 (Fisher’s exact test, p=0.12). In comparison, in 129/SvTer mice 50% of mice that had a SIRA 
on day 1 had a SIRA on day 2, whereas 78% of mice that had a non-SIRA on day 1 had a non-SIRA 
on day 2 (Fisher’s exact test, p=0.21).  
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When testing and retesting DBA/1J mice, only 12 of 95 mice reached the criteria to be included in 
experiment 2; which is presenting with a tonic seizure for two consecutive days. Of these 12 mice, 11 
mice exhibited a SIRA on the first and second day of testing. One mouse had a non-SIRA tonic seizure 
on the first day and a SIRA the second day.  
 
DISCUSSION 
There are a limited number of rat and mouse strains that can be used for studying SUDEP through 
AGS. However, rodent AGS models exhibit three main problems 1) rats do not die with AGS (for 
review see Ross and Coleman 8), 2) there is a small time frame in popular AGS mouse strains (DBA/2 
and DBA/1) for which AGS can occur, but  3) these two inbred strains available for AGS are fragile 
in nature and limit the ability to perform surgical techniques since it is becoming necessary. Our goal 
in this study was to offer additional mouse strains for AGS studies and, thus, we characterized AGS 
susceptibility in four strains of mice, extending the work of Fuller and Sjursen (1967). We included 
the commonly used DBA/2 and DBA/1 mouse strains, as well as the less well-studied BALB/c and 
129/SvTer mouse strains. Independent groups of mice were tested each week between 21-112 days of 
age. This was carried out in the absence of priming. We also investigated the determinism (i.e. innate 
consistency of the AGS response) in DBA/2 and 129/SvTer strains to address the feasibility of using 
case-crossover designs in pharmacological studies of SUDEP.   
 
Indeed, with the four mouse strains investigated, DBA/2J, DBA/1J, 129/SvTer and BALB/cJ, there 
were different patterns in the response to AGS and in the long-term sensitivity to AGS. These results 
converge and extend the findings of Fuller and Sjursen (1967) who studied the AGS susceptibility of 
eleven mouse strains, three of which we have tested (DBA/2, 129/SvTer, BALB/c), for 21 days only, 
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between ages 21 to 42 days. Here we show the progression of AGS with increasing ages, up to 112 
days of age (Figure 1). We also included DBA/1 mice, which have become a common model used in 
AGS research since the publication of Fuller and Sjursen (1967)4, 14. In terms of the evolution of the 
tonic seizure response in AGS, we see an extinction of the phenotype (DBA/2), stability of the 
phenotype (DBA/1), increasing of the phenotype (129/SvTer) and an absence of the phenotype 
(BALB/c). When looking at the pattern of the tonic seizure response with AGS (lethal or non-lethal), 
we see that the DBA/2 and DBA/1 strain show a majority of lethal tonic seizures, whereas the 
129/SvTer strain present a balanced response with both lethal and non-lethal tonic seizures.  
 
From our results we can conclude that the 129/SvTer mouse is an advantageous model of AGS. 
Effectively the 129/SvTer mouse 1) has a longer seizure susceptibility with age, 2) has a heavier body 
weights which makes it more relevant for invasive techniques, and 3) has an equivalent level of both 
lethal and non-lethal tonic seizures. This was found without any priming 6. With a longer seizure 
susceptibility (which may be due to slower hearing loss19) and less fragility, this strain is a valuable 
model to be used for studies of AGS and SUDEP, especially when surgical manipulations are 
necessary. With equivalent response rates to AGS of lethal and non-lethal tonic seizures, the 
129/SvTer strain provides one with the opportunity to investigate both the mechanism mediating 
lethality and the mechanism mediating survival. For example, this model could be very useful to 
address the role of the tonic seizure phase since it has been suggested that this later plays a significant 
role in SUDEP related to post-ictal generalized EEG suppression20, 21. 
 
In further investigation of the determinism of the AGS response, we showed that DBA/2J and 
129/SvTer mice did not consistently reproduce the SIRA or non-SIRA response following a tonic 
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seizure through additional testing. Effectively, approximately one third of the mice for both strains 
showed the alternative response during the second day of AGS testing (Figure 3). This suggests that 
case-crossover design studies should be carried out with caution as determinism is not observed in a 
notable number of subjects.  
 
When testing and retesting DBA/1J mice, all the animals did exhibit a SIRA on the second day of 
testing. This is not a surprise as these animals rarely exhibit a non-SIRA. Using this strain of mice was 
not relevant to testing determinism as they did not exhibit both SIRA and non-SIRA in response to 
sound stimulation. This results validates previous work by Faingold and others showing that in 
pharmacological studies of SUDEP, where a medication to prevent SUDEP is introduced prior to the 
second AGS test day, the reduction of the lethality of seizures observed is, indeed, due to the 
pharmacological intervention in this mouse strain 3, 4, 16, 22. Since we did not address any effects of 
priming in the present studies, these findings may not extend to studies where priming 14 has been 
used.  
 
If determinism was observed, the hypothesis of genetic factors is unlikely since these mice are inbred. 
One must consider epigenetic factors as more probable. Besides (epi)genetic factors, we also addressed 
the effects of experiencing AGS in 129/SvTer mice. Figure 4 shows the distribution of the mice that 
had a SIRA on test-day 5 considering the number of SIRA they demonstrated over the 4 preceding 
test days. One can observe that the probability to die on the 5th test day was directly correlated to the 
number of SIRA on previous testing days showing the experience matters and lethality begets lethality.  
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In conclusion, this work highlights the value of using the 129/SvTer strain for addressing SUDEP in 
AGS models due to their wider age range of susceptibility and heavier body weight. We also show 
that experience of lethality favors lethality. We failed to show that innate determinism is present in 
AGS response when priming is not used. Future studies will address if the 129/SvTer strain is 
susceptible to priming and, if observed, if the reproducibility of the AGS response exists. 
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KEY POINT BOX 
 
•  There are strain differences in AGS response with age between DAB/2J, DAB/1J, BALB/cJ 
and 129/SvTer mice.  
• Tonic seizure response to AGS with age becomes extinct in DBA/2, is stable in DBA/1, 
increases in 129/SvTer and is absent in BALB/c. 
• 129/SvTer is a valuable AGS model because of its long susceptibility, equal rates of lethal and 
non-lethal tonic seizures, and surgery compatibility. 
• In the 129/SvTer models of AGS, experience of lethality favors lethality through repeated AGS 
testing. 
• In investigating innate determinism of the AGS response, DBA/2J and 129/SvTer mice do 
not consistently reproduce the lethal or non-lethal AGS response. 
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Figure legends 
Figure 1. Percentages of specific AGS responses in four inbred strains of mice, DBA/2J, DBA/1J, 
BALB/cJ, and 129/SvTer, between day 21 and day 112 of age. Separate groups of mice were tested at 
each week. TCS=tonic-clonic seizure, D=death, S=seizure, TS=tonic seizure. (Average n=17-
25/group/week). 
Figure 2. Weight growth curves of 129/SvTer vs DBA/1J mices (23-88 days) fitted by non-linear 
mixed effects models, males and females (predicted values ± 95% confidence intervals). 
Figure 3. Percentages of mice in the DBA/2J (n=43) and 129/SvTer (n=33) strains that experienced 
SIRA then SIRA, non-SIRA then non-SIRA, SIRA then non-SIRA, or non-SIRA then SIRA responses 
across two consecutive days of AGS testing. 
Figure 4. Probability (%) to present a respiratory arrest on test-day 5 (Y axis) according to the number 
of respiratory arrests demonstrated over the 4 preceding test days in 129/SvTer mice (n=33). For 
example, a mouse which has experienced 3 respiratory arrests among the 4 preceding testing days has 
a 75% probability to experience a new respiratory arrest on test-day 5. 
 
